Related Experiment Video
Updated: Jan 28, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer
Mirco Compagnone1, Loredana Cifaldi2, Doriana Fruci1
1Paediatric Haematology/Oncology Department, Ospedale Pediatrico Bambino Gesù, 00146 Rome, Italy.
Abstract:
The endoplasmic reticulum (ER) aminopeptidases ERAP1 and ERAP2 are two multifunctional enzymes playing an important role in the biological processes requiring trimming of substrates, including the generation of major histocompatibility complex (MHC) class I binding peptides. In the absence of ERAP enzymes, the cells exhibit a different pool of peptides on their surface which can promote both NK and CD8+ T cell-mediated immune responses. The expression of ERAP1 and ERAP2 is frequently altered in tumors, as compared to their normal counterparts, but how this affects tumor growth and anti-tumor immune responses has been little investigated. This review will provide an overview of current knowledge on transcriptional and post-transcriptional regulations of ERAP enzymes, and will discuss the contribution of recent studies to our understanding of ERAP1 and ERAP2 role in cancer immunity.
Insights
Endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 are crucial for peptide trimming. Their altered expression in tumors impacts cancer immunity, affecting immune cell responses.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 trim substrates for MHC class I peptide generation.
- Absence of ERAP enzymes alters cell surface peptides, influencing NK and CD8+ T cell responses.
- ERAP1 and ERAP2 expression is frequently dysregulated in tumors.
Purpose of the Study:
- To review current knowledge on ERAP1 and ERAP2 regulation.
- To discuss the role of ERAP1 and ERAP2 in cancer immunity.
- To highlight recent findings on ERAP enzymes in tumor immunology.
Main Methods:
- Literature review of transcriptional and post-transcriptional regulations.
- Analysis of recent studies on ERAP1 and ERAP2 in cancer.
- Discussion of ERAP enzyme function in immune responses.
Main Results:
- ERAP enzymes are critical for generating MHC class I binding peptides.
- Altered ERAP expression in tumors can modulate anti-tumor immunity.
- ERAP dysregulation affects the peptide repertoire presented to immune cells.
Conclusions:
- ERAP1 and ERAP2 play a significant role in cancer immunity.
- Understanding ERAP regulation is key to developing cancer immunotherapies.
- Further research is needed to fully elucidate ERAP's impact on tumor growth and immune surveillance.
Related Concept Videos
Gene Regulation During Sporulation
Circadian Rhythms and Gene Regulation
Constitutive and Regulated Gene Expression
Master Transcription Regulators
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Epigenetic Regulation

